Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology

Details for Australian Patent Application No. 2009233925 (hide)

Owner IBC Pharmaceuticals, Inc.

Inventors Goldenberg, David M.; Chang, ChienHsing; Rossi, Edmund A.

Agent Davies Collison Cave

Pub. Number AU-A-2009233925

PCT Pub. Number WO2009/126558

Priority 12/396,605 03.03.09 US; 61/119,542 03.12.08 US; 12/396,965 03.03.09 US; 61/104,916 13.10.08 US; 61/043,932 10.04.08 US

Filing date 6 April 2009

Wipo publication date 15 October 2009

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

4 November 2010 PCT application entered the National Phase

  PCT publication WO2009/126558 Priority application(s): WO2009/126558

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009233940-Use of virus-induced gene silencing (VIGS) to down-regulate genes in plants

2009233913-Customer exclusive data